IMAC Holdings Earnings Perspective: Return On Capital Employed

According to data from Benzinga Pro, during Q1, IMAC Holdings‘s (NASDAQ:BACK) reported sales totaled $2.09 million. Despite a…

According to data from Benzinga Pro, during Q1, IMAC Holdings‘s (NASDAQ:BACK) reported sales totaled $2.09 million. Despite a 46.96% increase in earnings, the company posted a loss of $3.70 million. In Q4, IMAC Holdings brought in $3.47 million in sales but lost $6.97 million in earnings.

What Is ROCE?

Earnings data without context is not clear and can be difficult to base trading decisions on. Return on Capital Employed (ROCE) helps to filter signal from noise by measuring yearly pre-tax profit relative to capital employed by a business. Generally, a higher ROCE suggests successful growth of a company and is a sign of higher earnings per share in the future. In Q1, IMAC Holdings posted an ROCE of -3.71%.

It is important to keep in mind that ROCE evaluates past performance and is not used as a predictive tool. It is a good measure of a company’s recent performance, but does not account for factors that could affect earnings and sales in the near future.

ROCE is a powerful metric for comparing the effectiveness of capital allocation for similar companies. A relatively high ROCE shows IMAC Holdings is potentially operating at a higher level of efficiency than other companies in its industry. If the company is generating high profits with its current level of capital, some of that money can be reinvested in more capital which will generally lead to higher returns and, ultimately, earnings per share (EPS) growth.

For IMAC Holdings, a negative ROCE ratio of -3.71% suggests that management may not be effectively allocating their capital. Effective capital allocation is a positive indicator that a company will achieve more durable success and favorable long-term returns; poor capital allocation can be a leech on the performance of a company over time.

Upcoming Earnings Estimate

IMAC Holdings reported Q1 earnings per share at $-0.11/share, which did not meet analyst predictions of $-0.05/share.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Earnings Preview For Quest Diagnostics

Quest Diagnostics (NYSE:DGX) is set to give its latest quarterly earnings report on Thursday, 2022-07-21. Here's what investors need to know before the announcement. Analysts estimate that Quest Diagnostics will report an earnings per share (EPS) of $2.20.

DGX

Read More

Aptinyx: Q2 Earnings Insights

Aptinyx (NASDAQ:APTX) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Aptinyx beat estimated earnings by 7.14%, reporting an EPS of $-0.26 versus an estimate of $-0.28.

APTX